Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer
Cancer Letters · 2024-08 · 598 · 217117
DOI: 10.1016/j.canlet.2024.217117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-08. Verfasst von Xing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tumor Microenvironment, Epigenesis, Genetic, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences, Chinese Academy of Meteorological Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer cells rewire metabolism to sculpt the immune tumor microenvironment (TME) and propel tumor advancement, which intricately tied to post-translational modifications. Histone lactylation has emerged as a novel player in modulating protein functions, whereas little is known about its pathological role in pancreatic ductal adenocarcinoma (PDAC) progression. Employing a multi-omics approach encompassing bulk and single-cell RNA sequencing, metabolomics, ATAC-seq, and CUT&Tag methodologies, we unveiled the potential of histone lactylation in prognostic prediction, patient stratification and TME characterization. Notably, "LDHA-H4K12la-immuno-genes" axis has introduced a novel node into the regulatory framework of "metabolism-epigenetics-immunity," shedding new light on the landscape of PDAC progression. Furthermore, the heightened interplay between cancer cells and immune counterparts via Nectin-2 in liver metastasis with elevated HLS unraveled a positive feedback loop in driving immune evasion. Simultaneously, immune cells exhibited altered HLS and autonomous functionality across the metastatic cascade. Consequently, the exploration of innovative combination strategies targeting the metabolism-epigenetics-immunity axis holds promise in curbing distant metastasis and improving survival prospects for individuals grappling with challenges of PDAC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100023, PR China; Key Laboratory of Research in Pancreatic Tumor, Chinese…
Förderung
- CAMS Innovation Fund for Medical Sciences
- Chinese Academy of Meteorological Sciences
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Liu, X., Xiao, R., Fang, Y., Zhou, F., Gu, M., Luo, X., Jiang, D., Tang, Y., You, L., & Zhao, Y. (2024). Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Letters, 598, 217117. https://doi.org/10.1016/j.canlet.2024.217117
Vancouver
Wang X, Liu X, Xiao R, Fang Y, Zhou F, Gu M, et al. Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Letters. 2024;598:217117. doi:10.1016/j.canlet.2024.217117
BibTeX
@article{Wang2024,
author = {Wang, Xing and Liu, Xiaohong and Xiao, Ruiling and Fang, Yuan and Zhou, Feihan and Gu, Minzhi and Luo, Xiyuan and Jiang, Decheng and Tang, Yuemeng and You, Lei and Zhao, Yupei},
title = {Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer},
journal = {Cancer Letters},
year = {2024},
volume = {598},
pages = {217117},
doi = {10.1016/j.canlet.2024.217117}
}
EUVIMED